Press Releases on January 3, 2019 - EIN Presswire - Press Release Distribution Service

Published on January 3, 2019 - 13:00 GMT

BioXcel Therapeutics Reports Positive Human Proof-of-Concept Data for Acute Treatment of Agitation in Patients with Alzheimer’s ...

Primary endpoint (safety and tolerability) met, with clinical benefit observed in 7 of 10 patients Proof-of-Concept established in agitated patients across multiple underlying disorders including Alzheimer’s Disease, Schizophrenia, and Delirium Trial …

Distribution channels: Conferences & Trade Fairs

Published on January 3, 2019 - 13:00 GMT

Nuance to Present at 37th Annual J.P. Morgan Healthcare Conference

BURLINGTON, Mass., Jan. 03, 2019 (GLOBE NEWSWIRE) -- Nuance Communications, Inc. (NASDAQ: NUAN) today announced it will present at the 37th Annual J.P. Morgan Healthcare Conference in San Francisco on January 10, 2019 at 9:00 a.m. Pacific Time. A live …

Distribution channels: Conferences & Trade Fairs, Telecommunications ...

Published on January 3, 2019 - 13:00 GMT

ThreeD Capital Inc. Announces Commitment of USD$500,000 In TODAQ

TORONTO, Jan. 03, 2019 (GLOBE NEWSWIRE) -- ThreeD Capital Inc. (the “Company”) (CSE:IDK), a Canadian-based venture capital firm focused on investments in promising, early stage companies and ICOs with disruptive capabilities is pleased to announce that it …

Distribution channels: Banking, Finance & Investment Industry

Published on January 3, 2019 - 13:00 GMT

Fulgent Genetics and Columbia University Irving Medical Center Partner on Expanded Carrier Screening

TEMPLE CITY, Calif., Jan. 03, 2019 (GLOBE NEWSWIRE) -- Fulgent Genetics (NASDAQ: FLGT) and the Precision Genomics Laboratory (PGL), in collaboration with the Department of Obstetrics and Gynecology, at Columbia University Irving Medical Center (CUIMC) …

Distribution channels: Technology ...

Published on January 3, 2019 - 13:00 GMT

Intra-Cellular Therapies to Present at the 37th Annual J.P. Morgan Healthcare Conference

NEW YORK, Jan. 03, 2019 (GLOBE NEWSWIRE) -- Intra-Cellular Therapies, Inc. (Nasdaq:ITCI), a biopharmaceutical company focused on the development of therapeutics for central nervous system (CNS) disorders, today announced that Sharon Mates, Ph.D., Chief …

Distribution channels: Conferences & Trade Fairs, Healthcare & Pharmaceuticals Industry ...

Published on January 3, 2019 - 13:00 GMT

PRGX Announces Appointment of New Chief Financial Officer

ATLANTA, Jan. 03, 2019 (GLOBE NEWSWIRE) -- PRGX Global, Inc. (Nasdaq: PRGX), a global leader in Recovery Audit and Spend Analytics services, today announced that the Board of Directors has appointed Kurt Abkemeier as Chief Financial Officer, Treasurer and …

Distribution channels: Banking, Finance & Investment Industry, IT Industry ...

Published on January 3, 2019 - 13:00 GMT

Future Farm's Puerto Rico Affiliate Positioned to Launch Significant Expansion of Clínica Verde, the Island's Preeminent Provider ...

Vancouver, British Columbia, Jan. 03, 2019 (GLOBE NEWSWIRE) -- via NEWMEDIAWIRE -- Future Farm Technologies Inc. (the “Company” or “Future Farm”) (CSE: FFT) (OTCQB: FFRMF) is pleased to announce that its Puerto Rico subsidiary, FFPR, LLC (“FFPR”), which …

Distribution channels: Consumer Goods

Published on January 3, 2019 - 13:00 GMT

Jounce Therapeutics Completed Enrollment in First Cohort of Phase 1 Clinical Trial with its PD-1 Inhibitor, JTX-4014

CAMBRIDGE, Mass., Jan. 03, 2019 (GLOBE NEWSWIRE) -- Jounce Therapeutics, Inc. (NASDAQ: JNCE), a clinical-stage company focused on the discovery and development of novel cancer immunotherapies and predictive biomarkers, announced today that the company …

Distribution channels: Technology ...

Published on January 3, 2019 - 13:00 GMT

Replimune Highlights Company Progress and Expected 2019 Milestones Ahead of Presentation at the 37th Annual JPMorgan Healthcare ...

RP1: U.S. Enrollment Opened for Phase 1/2 Clinical Trial in Combination with Nivolumab in Patients with Solid Tumors RP1: Randomized Controlled Phase 2 Clinical Trial Alone and in Combination with Cemiplimab On Track to Initiate H1 2019 RP2: Phase 1 …

Distribution channels: Healthcare & Pharmaceuticals Industry ...

Published on January 3, 2019 - 13:00 GMT

InnerScope Hearing Technologies Inc. Announces its CEO is Bringing National Awareness to the Risk of Dementia from Untreated ...

InnerScope's CEO will be a regular featured guest on the Emmy Award winning TV and Radio Show "The Big Biz Show" (airs weekdays to 110 million households, 150 U.S radio stations and broadcasts over the Armed Forces Radio Network to 175 …

Distribution channels: ...

Published on January 3, 2019 - 13:00 GMT

Exela Technologies Acquires Healthcare Asset Adding Over $20 million of Annual Revenue

Transaction expected to contribute total revenue of over $170 million over the next seven years Exela’s Healthcare industry 2019 revenue expected to grow above 5% industry growth rate estimate IRVING, Texas, Jan. 03, 2019 (GLOBE NEWSWIRE) -- Exela …

Distribution channels: IT Industry ...

Published on January 3, 2019 - 13:00 GMT

Costamare Inc. Declares Quarterly Dividend on Its Preferred and Common Stock

MONACO, Jan. 03, 2019 (GLOBE NEWSWIRE) -- Costamare Inc. (the “Company”) (NYSE: CMRE) has declared cash dividends of US $0.476563 per share on its 7.625% Series B Cumulative Redeemable Perpetual Preferred Stock (the “Series B Preferred Stock”) (NYSE: CMRE …

Distribution channels: Banking, Finance & Investment Industry, Shipping, Storage & Logistics ...

Published on January 3, 2019 - 13:00 GMT

Minnesota State Bar Association Signs Agreement for December 2018 launch of Identillect’s Delivery Trust®

IRVINE, Calif., Jan. 03, 2019 (GLOBE NEWSWIRE) -- Identillect Technologies Corp. (the "Company" or "Identillect") (TSX-V: ID) (OTCQB: IDTLF) (Frankfurt: 8ID), a trusted leading provider of compliant email security, announces the …

Distribution channels: Business & Economy, IT Industry ...

Published on January 3, 2019 - 13:00 GMT

Lightbridge CEO to Participate in Workshop on Nuclear Power in the Middle East

RESTON, Va., Jan. 03, 2019 (GLOBE NEWSWIRE) -- Lightbridge Corporation (NASDAQ: LTBR), a nuclear fuel developer, announced today that Seth Grae, Chief Executive Officer, will participate in a workshop on Nuclear Power in the Middle East on January 11th, …

Distribution channels: Conferences & Trade Fairs ...

Published on January 3, 2019 - 13:00 GMT

OncoCyte Announces Transition to Ion Torrent Next-Generation Sequencing Platform

ALAMEDA, Calif., Jan. 03, 2019 (GLOBE NEWSWIRE) -- OncoCyte Corporation (NYSE American: OCX), a developer of novel, non-invasive tests for the early detection of cancer, today announced its successful transition to the Ion GeneStudio S5 next-generation …

Distribution channels: Banking, Finance & Investment Industry, Healthcare & Pharmaceuticals Industry ...

Published on January 3, 2019 - 13:00 GMT

Wave Life Sciences Duchenne Muscular Dystrophy Clinical Trial Selected for FDA Complex Innovative Trial Designs Pilot Program

Suvodirsen (WVE-210201) Phase 2/3 trial chosen in inaugural round of pilot program FDA pilot program is a 21st Century Cures Act initiative CAMBRIDGE, Mass., Jan. 03, 2019 (GLOBE NEWSWIRE) -- Wave Life Sciences Ltd. (NASDAQ: WVE), a biotechnology company …

Distribution channels: Technology ...

Published on January 3, 2019 - 13:00 GMT

MyoKardia to Present at 37th Annual J.P. Morgan Healthcare Conference

SOUTH SAN FRANCISCO, Calif., Jan. 03, 2019 (GLOBE NEWSWIRE) -- MyoKardia, Inc. (Nasdaq: MYOK), a clinical-stage biopharmaceutical company pioneering precision medicine for the treatment of cardiovascular diseases, today announced that Tassos Gianakakos, …

Distribution channels: Conferences & Trade Fairs, Healthcare & Pharmaceuticals Industry ...

Published on January 3, 2019 - 13:00 GMT

Hi-Crush Partners LP to Participate in Upcoming Investor Conference

HOUSTON, Jan. 03, 2019 (GLOBE NEWSWIRE) -- Hi-Crush Partners LP (NYSE: HCLP), or “Hi-Crush”, today announced that management will present and meet with investors at the Goldman Sachs Global Energy Conference in Miami, Florida on January 9, 2018. Hi-Crush’s …

Distribution channels: Conferences & Trade Fairs, Energy Industry ...

Published on January 3, 2019 - 13:00 GMT

Reed’s, Inc. Announces the Sale of Los Angeles Facility, Completing Transformation Plan Initiatives

Executed complete transition to asset-light sales and marketing focused business model Three-year co-packing agreement for the production of Reed’s glass beverages Agreement provides for the payment of royalties on Private Label sales for three years and …

Distribution channels: Food & Beverage Industry ...

Published on January 3, 2019 - 12:55 GMT

Elixinol Welcomes Hemp Industry Advocate Joy Beckerman As Regulatory Officer & Industry Liaison

DENVER , Jan. 03, 2019 (GLOBE NEWSWIRE) -- Elixinol, a wholly owned subsidiary of Elixinol Global (EXL) (ASX: EXL; OTC: ELLXF), announces Joy Beckerman’s appointment to Elixinol’s team starting January 1, 2019. In Beckerman’s role as Regulatory Officer and …

Distribution channels: Consumer Goods ...